课题基金 / 基金详情

Targeting SARS-CoV-2 Main protease and variants for effective antiviral development

Targeting SARS-CoV-2 Main protease and variants for effective antiviral development
针对 SARS-CoV-2 主要蛋白酶和变体进行有效的抗病毒开发
批准号:
452190
负责人:
Lemieux Joanne M
金额:
$62.7万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-09-01 至 2026-09-01

项目摘要

项目成果

Lemieux Joanne M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The global COVID-19 pandemic that has resulted in social, personal and economic upheaval will continue and secondary consequences, such overwhelmed health care systems, political unrest and food shortages, will add to the global hardship and death toll. V
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID-19 treatment
  • 批准号:
    443207
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Lemieux Joanne M
  • 依托单位:
COVID-19 Variant Network - Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID-19 treatment
  • 批准号:
    443337
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Lemieux Joanne M
  • 依托单位:
Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID-19 treatment
  • 批准号:
    429698
  • 项目类别:
    Operating Grants
  • 资助金额:
    $42.63万
  • 财政年份:
    2020
  • 负责人:
    Lemieux Joanne M
  • 依托单位:
Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection
  • 批准号:
    422721
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Lemieux Joanne M
  • 依托单位:
海外基金